ARTICLE | Company News
Cumberland Pharmaceuticals Inc sales and marketing update
October 3, 2016 7:00 AM UTC
Cumberland launched Ethyol amifostine in the U.S. to treat xerostomia in postoperative radiation of head and neck cancer and cumulative renal toxicity in ovarian cancer patients. In May, Cumberland a...